Serum soluble urokinase plasminogen activator receptor (suPAR) in early pregnancy prior to clinical onset of preeclampsia

suPAR: The Molecular Crystal Ball

(2013) Maria Thunø et al.   DISEASE MARKERS

Soluble urokinase plasminogen activator receptor (suPAR) levels in healthy pregnancy and preeclampsia

(2011) Gergely Toldi et al.   CLINICAL CHEMISTRY AND LABORATORY MEDICINE

Prognostic value of intact and cleaved forms of the urokinase plasminogen activator receptor in a retrospective study of 518 colorectal cancer patients

(2010) Anne Fog Lomholt et al.   ACTA ONCOLOGICA

Circulating soluble urokinase plasminogen activator receptor predicts cancer, cardiovascular disease, diabetes and mortality in the general population

(2010) J. Eugen-Olsen et al.   JOURNAL OF INTERNAL MEDICINE

Urokinase plasminogen activator system as a potential target for cancer therapy

(2009) Ahmed H Mekkawy et al.   Future Oncology

Release of the Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR) by Activated Neutrophils in Rheumatoid Arthritis

(2009) Boris K. Pliyev et al.   INFLAMMATION

The Global Impact of Pre-eclampsia and Eclampsia

(2009) Lelia Duley   SEMINARS IN PERINATOLOGY

Endoglin, PlGF and sFlt-1 as markers for predicting pre-eclampsia

(2008) Antonio De Vivo et al.   ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA

Placental protein 13 as an early marker for pre-eclampsia: a prospective longitudinal study

(2008) R Gonen et al.   BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY

Predictive value of angiogenic factors and uterine artery Doppler for early- versus late-onset pre-eclampsia and intrauterine growth restriction

(2007) F. Crispi et al.   ULTRASOUND IN OBSTETRICS & GYNECOLOGY